Composition comprising in vitro expanded T-lymphocytes and vessel formation inhibitors suitable in the treatment of cancer
- 专利权人:
- SentoClone International AB
- 发明人:
- Thorn, Magnus,Winqvist, Ola
- 申请号:
- AU2009270434
- 公开号:
- AU2009270434B2
- 申请日:
- 2009.07.17
- 申请国别(地区):
- AU
- 年份:
- 2015
- 代理人:
- 摘要:
- Improved cancer therapy using a combination treatment with tumour-reactive T-lymphocytes obtained by an
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- COMPOSITION COMPRISING IN VITRO EXPANDED T-LYMPHOCYTES AND VESSEL FORMATION INHIBITORS SUITABLE IN THE TREATMENT OF CANCER
- COMPOSITION COMPRISING IN VITRO EXPANDED T-LYMPHOCYTES AND VESSEL FORMATION INHIBITORS SUITABLE IN THE TREATMENT OF CANCER
- COMPOSITION COMPRISING IN VITRO EXPANDED T-LYMPHOCYTES AND VESSEL FORMATION INHIBITORS SUITABLE IN THE TREATMENT OF CANCER
- Immunotherapy in cancer treatment
- TUMOR LYMPHOCYTES PERMITTING FOR ADAPTIVE CELL THERAPY